首页> 外文期刊>Clinical and experimental ophthalmology >Resolution of primary acquired melanosis with atypia after minimal mitomycin C treatment.
【24h】

Resolution of primary acquired melanosis with atypia after minimal mitomycin C treatment.

机译:经过最小程度的丝裂霉素C治疗后,原发性黑色素沉着症伴非典型性消退。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The most effective dose of mitomycin C (MMC) in the treatment of primary acquired melanosis (PAM) with atypia of the conjunctiva and cornea has yet to be established. This case report describes successful treatment of PAM with atypia with a single four day cycle of 0.02% MMC.
机译:丝裂霉素C(MMC)在治疗结膜和角膜异型性原发性黑素病(PAM)中的最有效剂量尚未确定。该病例报告描述了非典型性PAM的成功治疗,其四天周期为0.02%MMC。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号